BioWorld

March 10, 2003

Congress Looking Into Law Requiring Trials For Children

WASHINGTON - Companies developing biologics that could be used off-label in children may end up having to run pediatric clinical trials. (BioWorld Today) Read More

Corus Raises $40M Privately For Phase II Asthma, CF Drugs

Lymphocytes Activate Plasma Cells To Generate Huge Antibody Quantities And Multiple Myeloma

Sopherion Gets $26M In Series A To Support Platforms, Pipeline

One-Man Company, Synergia, Gets $2M To Work On Migraine

Other News To Note

Correction

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for Jan 29, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 29, 2026.

Brain-derived tau in blood predicts stroke severity and outcome

BioWorld Science

Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

Centessa’s CNT-9982 shows promise for MDD

BioWorld Science

Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...

First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

BioWorld Science

Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...